Real‐World Evidence on Weight Loss and Safety With Semaglutide in Obesity Telehealth: A Large Retrospective Cohort Study
Findings suggest semaglutide treatment via telehealth can achieve trial-level weight loss with similar safety profiles, supporting telehealth as an evidence-based approach to medical weight management.
Authors
- Melynda Barnes (ORCID: https://orcid.org/0000-0001-5799-6265)
- Lauren Broffman (ORCID: https://orcid.org/0000-0003-0048-4474)
- David B. Allison (ORCID: https://orcid.org/0000-0003-3566-9399)
- Beverly G. Tchang (ORCID: https://orcid.org/0000-0002-2955-8089)
- Siew Yeen Chai (ORCID: https://orcid.org/0000-0001-7209-4112)
- Raoul Manalac
- Nicholas Samonas
Institutions
- Cornell University (US)
- Nautilus Ventures (US)
- Children's Nutrition Research Center at Baylor College of Medicine (US)
Publication Details
- Journal
- Obesity
- Published
- 2025-12-10
- DOI
- https://doi.org/10.1002/oby.70120
- Citations
- 1
- Primary Topic
- Bariatric Surgery and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 2.01